Evidence map›Paper›PMID 25793260›Full record

ArticlePloS one2015

Plasmodium vivax and Plasmodium falciparum at the crossroads of exchange among islands in Vanuatu: implications for malaria elimination strategies.

Chim W Chan, Naoko Sakihama, Shin-Ichiro Tachibana, Zulkarnain Md Idris, J Koji Lum, Kazuyuki Tanabe, Akira Kaneko

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04416945 nawithdrawnnot on this mapstarted 2020, after this paper: background citation

Targeting High-risk Populations With Enhanced Reactive Case Detection: a Study to Assess the Effectiveness and Feasibility for Reducing Plasmodium Falciparum and P. Vivax Malaria in Southern Lao Peoples Democratic Republic

TypeinterventionalSponsorUniversity of California, San FranciscoRan2020 to 2021Enrolled0ConditionsPlasmodium Falciparum Malaria, Plasmodium Vivax MalariaArmsHousehold Reactive Case Detection, RACD of cases' co-workers/co-travelers, Case Management and Follow-up
NCT05052502 nacompletednot on this mapstarted 2020, after this paper: background citation

Targeting High-risk Populations With Enhanced Reactive Focal Mass Drug Administration: A Study to Assess the Effectiveness and Feasibility for Plasmodium Falciparum and Plasmodium Vivax Malaria in Thailand

TypeinterventionalSponsorUniversity of California, San FranciscoRan2020 to 2022Enrolled14,977ConditionsPlasmodium Falciparum Malaria, Plasmodium Vivax MalariaArmsCase Management and Follow-up, Reactive focal mass drug administration (rfMDA)
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Higher Complexity of Infection and Genetic Diversity ofThe American journal of tropical medicine and hygiene · 2017
    Article
  8. Article
  9. Implications of Plasmodium vivax Biology for Control, Elimination, and Research.The American journal of tropical medicine and hygiene · 2016
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Chim W ChanIsland Malaria Group, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Naoko SakihamaLaboratory of Malariology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
Shin-Ichiro TachibanaLaboratory of Malariology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
Zulkarnain Md IdrisIsland Malaria Group, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
J Koji LumLaboratory of Evolutionary Anthropology and Health, Binghamton University, Binghamton, New York, United States of America; Department of Anthropology, Binghamton University, Binghamton, New York, United States of America; Department of Biological Sciences, Binghamton University, Binghamton, New York, United States of America.
Kazuyuki TanabeLaboratory of Malariology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
Akira KanekoIsland Malaria Group, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden; Department of Parasitology, Graduate School of Medicine, Osaka City University, Osaka, Japan; Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.
Osaka University · JPKarolinska Institutet · SEBinghamton University · USOsaka City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Understanding the transmission and movement of Plasmodium parasites is crucial for malaria elimination and prevention of resurgence. Located at the limit of malaria transmission in the Pacific, Vanuatu is an ideal candidate for elimination programs due to low endemicity and the isolated nature of its island setting. We analyzed the variation in the merozoite surface protein 1 (msp1) and the circumsporozoite protein (csp) of P. falciparum and P. vivax populations to examine the patterns of gene flow and population structures among seven sites on five islands in Vanuatu. Genetic diversity was in general higher in P. vivax than P. falciparum from the same site. In P. vivax, high genetic diversity was likely maintained by greater extent of gene flow among sites and among islands. Consistent with the different patterns of gene flow, the proportion of genetic variance found among islands was substantially higher in P. falciparum (28.81-31.23%) than in P. vivax (-0.53-3.99%). Our data suggest that the current island-by-island malaria elimination strategy in Vanuatu, while adequate for P. falciparum elimination, might need to be complemented with more centrally integrated measures to control P. vivax movement across islands.

Indexed as

Gene FlowGenetic VariationGenotypeGeographyHumansMalaria, FalciparumMalaria, VivaxMolecular Sequence DataPlasmodium falciparumPlasmodium vivaxProtozoan ProteinsVanuatuProtozoan Proteins

Identifiers

PMID25793260
PMCPMC4368729
OpenAlexW2068344184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.